Sort
82,697 grants matching “vaccine development”
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$1,801,435Giorgio Trinchieri · Basic Sciences · Z01 · FY2007 · CA
T Cell Immune Responses To HIV And Other Pathogens
$1,800,765Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
NONHUMAN PRIMATE (NHP) CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH DEVELOPMENT
$1,800,685Amitinder Kaur · Tulane University Of Louisiana · N01 · FY2020 · AI
Vaccine and Infection Induced Immunity in the Young and Aged
$1,800,565Rafi Ahmed · Emory University · U19 · FY2025 · AI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$1,800,256Jay A Berzofsky · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Eliciting VRC01-like bNAbs by Specifically Designed Env Immunogens
$1,800,250Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2018 · AI
Prospective annual estimates of influenza vaccine effectiveness and burden of disease
$1,800,000Michael L Jackson · Kaiser Foundation Research Institute · U01 · FY2020 · IP
Mandatory_Estimates of Vaccine Effectiveness Against Medically-Attended, PCR-Confirmed Influenza in West South Central U.S.
$1,800,000Manjusha Gaglani · Scott And White Memorial Hospital · U01 · FY2020 · IP
US Influenza Vaccine Effectiveness Network
$1,799,999Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2018 · IP
US Influenza Vaccine Effectiveness Network
$1,799,998Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2019 · IP
Immunologic &Virologic Features of Early HIV Infection
$1,799,925University Of California San Francisco · U01 · FY2002 · AI
Alphavirus Replicon Vaccines against Botulinum Neurotox*
$1,799,459Alphavax Human Vaccines, Inc. · U01 · FY2005 · AI
A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana
$1,799,067Roger L Shapiro · Harvard School Of Public Health · U01 · FY2023 · AI
The Multi-omics Vaccine Evaluation (MOVE) Consortium
$1,798,519Bryan Briney · Scripps Research Institute, The · P01 · FY2023 · AI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins
$1,798,354Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Asthma Endotypes: Mechanisms and Consequences for Airway Epithelium and Mucus
$1,797,903David J Erle · University Of California, San Francisco · U19 · FY2021 · AI
Role of B Lymphocytes In HIV Infection And Pathogenesis
$1,797,445Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
The AIDS Linked to the Intravenous Experience (ALIVE) Study
$1,797,375Gregory D Kirk · Johns Hopkins University · U01 · FY2014 · DA
Center for Immunotherapeutic Transport Oncophysics
$1,797,348Haifa Shen · Methodist Hospital Research Institute · U54 · FY2020 · CA
Adjuvant Comparison and Characterization of Peanut Antigen
$1,796,813Herman Staats · Duke University · N01 · FY2023 · AI
The Multi-omics Vaccine Evaluation (MOVE) Consortium
$1,796,659Bryan Briney · Scripps Research Institute, The · P01 · FY2025 · AI
Establish a Public Private Partnership for COVID19 Research
$1,796,424Stacey Adam · Foundation For The Nih · OT2 · FY2020 · OD
Evaluate Whether Passive Immunization of Broadly Neutralizing Antibodies in Owl Monkeys Can Block HIV Infection
$1,796,343Ronald Veazey · Tulane University Of Louisiana · N01 · FY2022 · AI
Adjuvant Development within the context of a vaccine to protect against B. pertussis for use in newborns.
$1,795,983Boston Children'S Hospital · N01 · FY2018 · AI
Immunization and Immune Monitoring
$1,795,460David C Montefiori · Duke University · U19 · FY2009 · AI